Bio-Connect

Lysozyme [9001-63-1]

16-14-122519
Athens Research
Protein IDP61626
Product group Proteins / Signaling Molecules
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Athens Research
  • Product Name
    Lysozyme [9001-63-1]
  • Delivery Days Customer
    9
  • Applications Supplier
    In Vitro Diagnostic, Aptamers, Infection, Inflammation
  • Certification
    Research Use Only
  • Estimated Purity
    ≥95% by SDS-PAGE.
  • Protein IDP61626
  • Protein Name
    Lysozyme C
  • Scientific Description
    Lysozyme is a compact, globular protein found abundantly in the specific granules of human polymorphonuclear leukocytes, as well as in various secretions such as tears, saliva, and egg white. Its primary function is to provide innate immune defense by hydrolyzing the bèta-1,4 glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine residues in the peptidoglycan layer of bacterial cell walls, particularly targeting Gram-positive bacteria. Lysozyme’s active site, located in a deep groove on its surface, binds to bacterial polysaccharide chains, facilitating their cleavage and leading to bacterial lysis and death. Beyond its antibacterial role, lysozyme exhibits antifungal and antiviral activities and modulates immune responses by influencing cytokine production and inflammation. Clinically, lysozyme has been explored for therapeutic applications in infections, inflammation, cancer, and wound healing, and is used as a natural preservative in food and pharmaceuticals due to its antimicrobial properties. Its broad functionality and safety profile make lysozyme valuable in biotechnology, medicine, and industry.
  • Shelf life instruction
    more then 1 year
  • Source
    Neutrophils shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.
  • Storage Instruction
    ≤ -20°C
  • UNSPSC
    12352202

References

  • Epaud, R., et al., (2019), 'Bacterial killing is enhanced by exogenous administration of lysozyme in the lungs', Respir. Med and Res 76: pp 22–27.
    Read this paper